García Luz Stella, Bravo Luis Eduardo, Collazos Paola, Ramírez Oscar, Carrascal Edwin, Nuñez Marcela, Portilla Nelson, Millan Erquinovaldo
Registro Poblacional de Cáncer de Cali. Cali, Colombia.
Departamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.
Colomb Med (Cali). 2018 Mar 30;49(1):109-120. doi: 10.25100/cm.v49i1.3853.
The Population Cancer Registry of Cali (RPCC) has operated since 1962, disseminating high quality information to provide a framework to assess and control the burden of cancer in Cali.
The collection of new cancer cases in permanent residents of Cali is done through active search in and notification from hospitals, and public and private laboratories. The Secretary of Municipal Public Health provides individual information on general mortality and death from cancer. Tumors are coded with ICDO-3 and mortality with ICD-10. Presented rates are standardized by age and trends are assessed by estimating the percentage annual change using the regression analysis in JoinPoint. The 5-year net survival was analyzed with the Pohar-Perme estimator.
The 88.5% of the registered cancers had morphological verification (MV). The proportion of unknown primary site represented 5% and the death certificate only cases (DCO) varied between 0 to3% depending on the cancer site. All deaths were certified by a physician, 94.2% of cancer deaths were correctly certified. The ill-defined site proportion was 5.3% and that of uterine cancer not specified (C55) was 0.5%. For survival analysis, existing data collection procedure and infrastructure ensures assessment of the patient's vital status and follow-up, with an average lost to follow-up of 13.2%.
The information has been published in the eleven volumes of "Cancer Incidence in Five Continents" confirming high quality of the collected data. The RPCC PCRC has also participated in the Concord Study and is participating in SURVCAN-3.
卡利市人口癌症登记处(RPCC)自1962年开始运作,传播高质量信息以提供一个评估和控制卡利市癌症负担的框架。
通过在医院以及公共和私人实验室进行主动搜索和通知来收集卡利市常住人口中的新癌症病例。市公共卫生秘书提供关于总体死亡率和癌症死亡的个人信息。肿瘤用ICDO - 3编码,死亡率用ICD - 10编码。呈现的发病率按年龄标准化,趋势通过使用JoinPoint中的回归分析估计年度变化百分比来评估。5年净生存率用Pohar - Perme估计器进行分析。
88.5%的登记癌症病例有形态学验证(MV)。未知原发部位的比例为5%,仅死亡证明病例(DCO)根据癌症部位在0%至3%之间变化。所有死亡均由医生认证,94.2%的癌症死亡认证正确。定义不明确的部位比例为5.3%,未指定的子宫癌(C55)比例为0.5%。对于生存分析,现有的数据收集程序和基础设施确保了对患者生命状态的评估和随访,平均随访失访率为13.2%。
该信息已发表在《五大洲癌症发病率》的十一卷中,证实了所收集数据的高质量。卡利市人口癌症登记处(RPCC)也参与了一致性研究,并正在参与SURVCAN - 3。